EM

Eric Moessinger

Partner at NanoDimension

Redwood City, California

Overview 

Eric Moessinger is a Partner at +ND Capital, with a background in Venture Capital and Private Equity. He has successfully invested in a range of companies across various sectors, including Semiconductors and BioTech, with notable investments in companies like SQZ Biotech and Twist Bioscience. Moessinger holds a Master's degree from The London School of Economics and Political Science, and has previous experience as a Senior Associate Consultant at Bain & Company. His expertise in due diligence and entrepreneurship has been instrumental in his successful investments in startups at different stages of growth.

Work Experience 

  • Partner

    2008 - Current

    NanoDimension is a venture capital firm investing in disruptive technologies at the convergence of the life, physical and data sciences. Focus on life science related investments at +ND. Joined in 2008 as the first employee of +ND’s Bay Area office. Currently serve on the board of directors of Emulate, Visby, Serotiny, Partillion and AIRNA, and observe on the boards of Inscripta, Lightcast and IonPath. Previously served as a board member at Icosavax (Nasdaq: ICVX) and SQZ (NYSE: SQZ), and observed on the board of ARMO (acquired by Lilly) and Twist (Nasdaq: TWST). Helped lead +ND’s investments in Orca and Octant.

NanoDimension is a venture capital firm investing in disruptive technologies in and at the convergence of the life and physical sciences.

  • Senior Associate Consultant

    2005 - 2008

Articles About Eric

Relevant Websites